Press Releases April 28, 2026 04:14 PM

Codere Online Announces Filing of 2025 Annual Report on Form 20-F

Codere Online files its 2025 Annual Report on Form 20-F, continuing transparency with shareholders.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn

Codere Online Luxembourg, a leading online gaming operator in Spain and Latin America, announced the filing of its annual report on Form 20-F for the fiscal year ending December 31, 2025, with the U.S. Securities and Exchange Commission. The company encourages digital review of the report to reduce environmental impact, while providing shareholders the option to request a physical copy for free. Codere Online operates both online sports betting and online casino services across core markets including Spain, Mexico, Colombia, Panama, and Argentina, supported by its parent Codere Group's physical gaming presence.

Codere Online Announces Filing of 2025 Annual Report on Form 20-F
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Codere Online filed its 2025 Form 20-F annual report with the SEC, providing audited financial statements.
  • The company promotes environmental sustainability by encouraging shareholders to view the report digitally.
  • Codere operates online gaming platforms and benefits from an omnichannel presence through its parent group’s physical casinos in Latin America.

Luxembourg, Grand Duchy of Luxembourg, April 28, 2026 (GLOBE NEWSWIRE) – Codere Online Luxembourg, S.A. (Nasdaq: CDRO / CDROW) (the “Company” or “Codere Online”), a leading online gaming operator in Spain and Latin America, today announced that it has filed with the U.S. Securities and Exchange Commission (“SEC”) its annual report on form 20-F for the year ended December 31, 2025 (the “2025 20-F”).  

A copy of the 2025 20-F is available in the SEC Filings section of the Company's website: www.codereonline.com/financials-and-filings.

In order to minimize the environmental impact of its annual report by reducing paper consumption, the Company encourages its shareholders to read it in digital format. However, Company shareholders willing to receive a hard copy of this document, which contains the Company’s audited financial statements, may do so, free of charge, upon request addressed to [email protected].

About Codere Online

Codere Online refers, collectively, to Codere Online Luxembourg, S.A. and its subsidiaries. Codere Online launched in 2014 as part of the renowned casino operator Codere Group. Codere Online offers online sports betting and online casino through its state-of-the art website and mobile applications. Codere currently operates in its core markets of Spain, Mexico, Colombia, Panama and Argentina. Codere Online’s online business is complemented by Codere Group’s physical presence throughout Latin America, forming the foundation of the leading omnichannel gaming and casino presence.

Contacts:

Investors and Media
Guillermo Lancha
Director, Investor Relations and Communications
[email protected]
(+34) 628.928.152


Risks

  • The report highlights reliance on key markets in Spain and Latin America, exposing the company to regional regulatory and economic uncertainties.
  • The online gaming sector is subject to changing legal frameworks and competition, which may impact future growth.
  • Environmental initiatives like digital reporting may have minimal direct shareholder impact but reflect broader corporate responsibility efforts.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026